insights_auto
Why is ONCY down 8.63%?
Dive Deeperchevron_right
ONCY:NASDAQ
Oncolytics Biotech Inc
$0.54
arrow_downward
-8.63%(-0.051) 1D
$0.55
arrow_upward
+1.75% (+0.0095)bedtimeAfter hours
Closed: Oct 8, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.60
High
$0.61
Low
$0.54
Mkt. cap
69.19M
Avg. vol.
1.02M
Volume
1.08M
52-wk high
$1.32
52-wk low
$0.54
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
Open
$0.60
High
$0.61
Low
$0.54
Mkt. cap
69.19M
Avg. vol.
1.02M
Volume
1.08M
52-wk high
$1.32
52-wk low
$0.54
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
News stories
From web sources and news partners
AD HOC NEWS
·
1 day ago
Oncolytics Biotech stock heads toward a November 19 board vote
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websiteoncolyticsbiotech.com